8.59 -0.09 (-1.04%)
ISIS
| Trade ISIS now with |
|
Stock Details
Last Trade:8.59 Change:-0.09 (-1.04%) Prev Close:8.68 Open: 8.67 Days Range:8.50 – 8.67 52 Week Range: 6.25 - 9.61 Volume:235270 P/E: N/AEPS:-0.79
View AllRecent Alerts 02/09/12
Recent Alert on 01/04/12 at 8:34am
Biogen (BIIB), Isis Pharma (ISIS) Enter ISIS-SMNRx Development Collaboration; Isis May Get Up to $299M
Biogen (BIIB), Isis Pharma (ISIS) Enter ISIS-SMNRx Development Collaboration; Isis May Get Up to $299M
Biogen Idec (Nasdaq: BIIB) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) have entered into an exclusive, worldwide option and collaboration agreement under which the companies will develop and commercialize Isis’ antisense investigational drug,... Read More
Recent Alert on 01/04/12 at 8:34am
Biogen (BIIB), Isis Pharma (ISIS) Enter ISIS-SMNRx Development Collaboration; Isis May Get Up to $299M
Biogen (BIIB), Isis Pharma (ISIS) Enter ISIS-SMNRx Development Collaboration; Isis May Get Up to $299M
Recent Alert on 12/20/11 at 8:07am
Isis Pharma (ISIS) Initiates ISIS-FGFR4Rx Phase 1 as Obesity Treatment
Isis Pharma (ISIS) Initiates ISIS-FGFR4Rx Phase 1 as Obesity Treatment
Recent Alert on 12/20/11 at 8:07am
Isis Pharma (ISIS) Initiates ISIS-FGFR4Rx Phase 1 as Obesity Treatment
Isis Pharma (ISIS) Initiates ISIS-FGFR4Rx Phase 1 as Obesity Treatment
View AllRecent Press Releases
Press Release on 02/08/12 at 7:00am
Isis Pharmaceuticals to Present at Leerink Swann's 2012 Global Healthcare Conference
Isis Pharmaceuticals to Present at Leerink Swann's 2012 Global Healthcare Conference